ECG AI-Guided Screening for Low Ejection Fraction

Last updated: May 30, 2023
Sponsor: Mayo Clinic
Overall Status: Completed

Phase

N/A

Condition

Chest Pain

Heart Failure

Congestive Heart Failure

Treatment

AI-enabled ECG-based Screening Tool

Clinical Study ID

NCT04000087
19-003137
  • Ages > 18
  • All Genders

Study Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Primary care clinicians who are part of a participating care team that care for adultpatients and have the ability to order ECG and TTE (this includes physicians, nursepractitioners, and physician assistants).

Exclusion

Exclusion Criteria:

  • Primary care clinicians working in pediatrics, acute care, nursing homes, and residentcare teams.

Study Design

Total Participants: 358
Treatment Group(s): 1
Primary Treatment: AI-enabled ECG-based Screening Tool
Phase:
Study Start date:
June 26, 2019
Estimated Completion Date:
November 01, 2020

Connect with a study center

  • Mayo Clinic in Rochester

    Rochester, Minnesota 55905
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.